Quantification of two-dimensional tumor growth in window chambers revealed that the proangiogenic effect of erythropoietin was associated with a significant increase in tumor growth by 66% and 42% on days 2 and 4, respectively, compared to controls (P<0.001, figure 1D, table 2). The gene discussed is EPO; the disease is neoplasm.